The commercial leader’s path to the top job

A commercial or marketing leader earns a real shot at CMO to CEO healthcare progression only by building muscles the growth seat never requires: P&L ownership, clinical credibility and board-level financial fluency. This piece maps where commercial leaders in Indian hospital groups typically fall short of that case, and the deliberate exposure that closes the gap.

Ask anyone who sits on a hospital group’s board how a CEO shortlist gets built, and the pattern repeats itself. A clinician who has learned to read a balance sheet. An operations head who has run a flagship facility through a NABH survey and come out the other side. Occasionally a CFO who has picked up enough clinical fluency to sit across from a medical director without flinching. A commercial or marketing leader, however much revenue they have built, is rarely on that first list — and when one is, it is usually because a board member asked why not.

That question is worth taking seriously, because the honest answer is not prejudice. Running demand generation and running a hospital business are different disciplines, and most commercial leaders have never had to prove they can do the second one. Getting from a CMO or growth seat to a credible CEO or group-CEO candidate is not a promotion with a bigger title attached. It is a different job, built on muscles the commercial chair does not naturally develop.

I have sat on the growth side of a multi-unit hospital group long enough to watch this gap up close, and to try, imperfectly, to close it in my own path — mostly the years spent building a digital team that had to earn its seat at every table it wanted into. What follows is what I think actually separates a commercial leader who gets taken seriously for the top job from one who stays permanently adjacent to it.

What the commercial seat teaches, and what it does not

A good CMO or growth leader in Indian private healthcare learns to read demand with real precision — which specialty is pulling enquiries, which channel is converting, where the funnel breaks between a Google search and a booked appointment. That is genuine, hard-won operating knowledge, and boards underrate it. But it is knowledge of one input into the business, not the business itself.

A CEO candidate has to hold the whole picture at once: occupancy against capacity, payer mix against margin, doctor recruitment against service-line strategy, capital allocation against three-year growth plans. Commercial leaders tend to arrive at that table fluent in the top of the funnel and largely silent on everything below it — bed utilisation, case mix, cost per procedure, the levers a unit head actually pulls on a bad month. That silence is what a board hears as “not ready,” even when nobody says it directly.

None of this means the commercial vantage point is worthless to a CEO search — the opposite, in fact. A leader who has actually built and defended a demand engine understands revenue in a way many operations-first candidates never do, because they have had to argue for every rupee of it in front of sceptical unit heads. The gap is not aptitude. It is exposure. Nobody handed a commercial leader the rest of the business to practise on, and until someone does, or a leader goes and finds that exposure deliberately, the fluency simply does not exist yet.

P&L ownership, not a marketing budget defended well

The single biggest tell, in my experience, is the difference between defending a marketing budget and owning a P&L line with your name on it. A commercial leader who has only ever protected their own spend — justified cost per lead, argued for a bigger digital allocation — has practised a narrower skill than one who has sat in the unit P&L review and answered for revenue, cost and margin together, including the parts that have nothing to do with marketing.

Part of the confusion is definitional — what the hospital CMO role owns has widened over the last several years, and it is easy to mistake that widened scope for P&L ownership when it is still, underneath, a cost centre with a growth mandate. The way to build real ownership is not to ask for a bigger marketing budget. It is to ask for a P&L, even a small one — a new vertical, a single unit, a service line with its own numbers — and to own it end to end, including the uncomfortable months. Anyone can present a growth story when the trend line is up. What a board is actually testing for is whether you can stand in a review and explain a miss without deflecting it onto the sales team, the season, or a competitor’s pricing. That single habit, repeated over several quarters, is what starts to read as CEO material rather than a very good head of marketing.

Credibility with clinical leadership and the medical director

No hospital CEO search gets far without the medical director’s tacit approval, and that approval is earned in rooms with no marketing agenda at all — a mortality and morbidity review, a case-mix discussion, a clinical governance meeting a commercial leader was invited to sit in on rather than present at. Showing up in those rooms, listening more than talking, and asking questions that show you understand clinical trade-offs rather than just demand implications, does more for a CEO case than another quarter of strong enquiry numbers.

The trap to avoid is treating clinical leadership as a stakeholder group to be managed with the same tools used on a marketing campaign — a deck, a data point, a persuasive narrative. Clinicians can tell the difference between someone building genuine operational understanding and someone building a relationship for political cover. The former takes years. There is no shortcut, and pretending otherwise is usually visible within a single conversation.

Board-level financial literacy is not optional

Most commercial leaders can read a funnel report cold and a board financial pack only in outline. That gap closes slowly, through repetition, not through a weekend course. Sitting in front of a board and being asked to walk through EBITDA margin by unit, working capital cycles, or the capital allocation logic behind a new block of beds, is a different skill from presenting a demand dashboard, and it shows immediately when someone has not done the reps.

The fastest way to close this gap is to ask to sit in board and audit committee sessions before you are the one presenting — as an observer on a subsidiary board, in a finance sub-committee, wherever the group will let you in. Watch how the CFO frames a bad quarter. Notice which questions directors actually ask versus which ones a commercial leader assumes they will ask. Most of what passes for board-level financial literacy is simply having sat through enough of these sessions to know the rhythm of the conversation, not a technical skill learned in isolation.

Operational fluency beyond demand generation

A growth leader’s instinct is to solve every problem with more or better demand. A CEO candidate has to be equally comfortable with the supply side — capacity planning, staffing ratios, procurement cycles, the operational reasons a unit cannot simply “convert more” even when the funnel says it should. This is the part of the transition that is genuinely uncomfortable, because it means admitting how much of a hospital’s day-to-day reality sits outside anything a commercial function touches.

The practical fix is deliberate exposure, not a title change. Ask to shadow a unit head through a month of operations reviews. Sit in on a capacity planning meeting before the next OT block gets allocated. None of this makes a commercial leader an operations expert, and it should not try to — the value is in knowing enough to ask sharp questions and to recognise when a growth plan is operationally unrealistic before it reaches the board, rather than after it fails in execution.

In a multi-unit group this exposure has a natural structure already built into it, if a commercial leader is willing to use it. Subsidiary boards, unit-level P&L reviews and cross-functional steering committees exist precisely because no single unit head can hold every function’s detail in their own head. Asking to sit on a subsidiary board, even in an observer capacity at first, puts a growth leader in the room where operational trade-offs get argued in language that has nothing to do with a funnel — capital sanction limits, staffing cost ratios, equipment amortisation — long before they need to defend those trade-offs themselves.

Where commercial leaders typically fall short

• Fluency in demand and conversion, near-silence on cost structure, staffing ratios and capacity constraints.
• A track record of defending a function’s budget, not of owning a P&L that includes lines they do not control.
• Relationships with clinical leadership built around campaigns and launches, not around governance and case-mix conversations.
• Confidence presenting a funnel dashboard, discomfort presenting a full financial pack unprompted.
• A growth narrative that assumes more demand solves problems capacity, staffing or pricing actually caused.

None of these are disqualifying on their own. Taken together, and left unaddressed for several years, they are why boards default back to clinical or operations candidates even when a commercial leader has built the group’s most visible growth story.

The mindset shift: from driving growth to owning the business

The transition I made earlier in my own path — the digital head to growth leader move — taught me how much of a specialist’s identity has to be unlearned to take on a broader mandate. The move toward a CEO track asks for a second, larger version of the same unlearning. A growth leader’s success is measured by a number that goes up. A CEO’s success is measured by a business that holds together — margin, quality, doctor retention, capital discipline and growth all at once, with none of them allowed to dominate the others indefinitely.

That shift shows up in small decisions before it shows up in a title. Do you argue for the marketing budget that maximises this quarter’s enquiries, or the one that protects margin across the group’s weaker units too? Do you keep pitching brand as a demand asset because it is the story your own function looks best telling, or do you say plainly when a service line’s real constraint sits somewhere brand cannot reach? Boards notice which answer a commercial leader gives long before they open a CEO search.

If you are building this case over the next few years

This is not a sequence you complete in a single budget cycle. It is closer to a five-to-seven-year case, built in layers, most of it visible only in retrospect.

• Ask for a P&L, not a bigger marketing budget — a vertical, a unit, anything with your name against the whole number, not just the spend line.
• Get into clinical governance rooms as a listener before you ever need clinical leadership’s support for something you want.
• Sit in board and finance sub-committee sessions as an observer until the rhythm of that conversation is familiar, not novel.
• Shadow operations reviews deliberately — capacity, staffing, procurement — until a growth plan’s operational limits are obvious to you before someone else points them out.
• Practise presenting a full financial picture, not a demand dashboard, whenever the opportunity comes up, even informally.
• Say out loud, in reviews, when your own function’s numbers are not the group’s biggest problem that quarter. That kind of honesty is rare and it is remembered.

Do this consistently and the CEO or group-CEO conversation stops being something you have to argue for. It becomes the obvious next question a board asks itself.

The commercial leaders who get taken seriously for the top job are not the ones who built the biggest funnel. They are the ones who stopped treating the funnel as the whole business the day their ambition outgrew it.

Questions people ask